* Azenta Inc AZTA.OQ reported quarterly adjusted earnings
of 18
cents per share for the quarter , higher than the same quarter
last year, when the company reported EPS of 13 cents. The mean
expectation of eight analysts for the quarter was for earnings
of 10 cents per share. Wall Street expected results to range
from 5 cents to 13 cents per share.
* Revenue fell 1.3% to $170.06 million from a year ago;
analysts
expected $169.61 million.
* Azenta Inc's reported EPS for the quarter was a loss of 10
cents.
* The company reported a quarterly loss of $4.98 million.
* Azenta Inc shares had fallen by 5.1% this quarter and
lost 29.4%
so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"
Wall Street's median 12-month price target for Azenta Inc is
52.50
This summary was machine generated from LSEG data November 13 at
02:26 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.10 0.18 Beat
Jun. 30 2024 0.07 0.16 Beat
Mar. 31 2024 0.02 0.05 Beat
Dec. 31 2023 -0.03 0.02 Beat